Dr. Klairmont is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
NYU Langone Health
550 1st Ave
New York, NY 10016- Is this information wrong?
Education & Training
- Rush Medical College of Rush University Medical CenterClass of 2014
- University of TennesseeResidency, Pathology-Anatomic and Clinical
Certifications & Licensure
- NY State Medical License 2020 - 2026
- PA State Medical License 2020 - 2021
Publications & Presentations
PubMed
- 5 citationsCo-occurring rearrangements of DUSP22 and TP63 define a rare genetic subset of ALK-negative anaplastic large cell lymphoma with inferior survival outcomes.Matthew M. Klairmont, Nicholas Ward> ;Leukemia & Lymphoma. 2021 Oct 6
- 2 citationsIn a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.Tauangtham Anekpuritanang, Matthew M. Klairmont, Joel F. Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil K. Chandra, Yiwei Liu, Heather L. Mulder, John Easton, ...> ;Blood Advances. 2021 Sep 24
- 4 citationsClinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.Matthew M. Klairmont, Yinmei Zhou, Cheng Cheng, Ching-Hon Pui, Sima Jeha, Tanja A. Gruber, Yiwei Liu, Hiroto Inaba, John K. Choi> ;Modern Pathology. 2021 Jun 19
- Join now to see all
Journal Articles
- The Comparative Sensitivity of Immunohistochemical Markers of Megakaryocytic Differentiation in Acute Megakaryoblastic LeukemiaNour Yadak, Matthew M Klairmont, Deepthi Hoskoppal, American Journal of Clinical Pathology
Professional Memberships
- Society for Hematopathology - SHMember
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: